Browsing: Rescheduling

Last Thursday, we learned that the DEA’s marijuana rescheduling hearings are delayed until early next year. We also saw the list of 25 participants invited by…

The American Institute of CPAs (AICPA) on Tuesday sent a letter to the Department of Treasury and Internal Revenue Service (IRS) requesting guidance for cannabis businesses…

The intersection of CBD (cannabidiol) and the tobacco industry is evolving rapidly, with the potential rescheduling of cannabis from Schedule I to Schedule III expected to…

Find us in your favorite podcast app: Spotify SoundCloud iTunes Stitcher In this episode of the Ganjapreneur Podcast, host TG Branfalt sits down with Jessica McElfresh,…

Yesterday, the Drug Enforcement Administration (DEA) near-noticed a hearing for its marijuana rescheduling proposal. The hearing would begin on December 2, 2024 at 9 a.m. ET,…

Although many cannabis experts and industry insiders were hoping to see a change in cannabis’ federal classification before the upcoming Presidential election in November, the Drug…

The Minority Cannabis Business Association (MCBA) has issued a report detailing that the sector stands to create more than 50,000 new jobs by 2030 if the…

The Department of Justice (DOJ) has proposed moving cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a change reflecting its widely…

In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice…

The Office of National Drug Policy (ONDCP) director Dr. Rahul Gupta, often referred to as President Joe Biden’s appointed “drug czar,” spoke about the ongoing discussion…